Cargando…

decompTumor2Sig: identification of mutational signatures active in individual tumors

BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krüger, Sandra, Piro, Rosario M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472187/
https://www.ncbi.nlm.nih.gov/pubmed/30999866
http://dx.doi.org/10.1186/s12859-019-2688-6
_version_ 1783412194892840960
author Krüger, Sandra
Piro, Rosario M.
author_facet Krüger, Sandra
Piro, Rosario M.
author_sort Krüger, Sandra
collection PubMed
description BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of such mutational processes can be modeled by mutational signatures, of which two different conceptualizations exist: the model introduced by Alexandrov et al., Nature 500:415–421, 2013, and the model introduced by Shiraishi et al., PLoS Genetics 11(12):e1005657, 2015. The initial identification and definition of mutational signatures requires large sets of tumor samples. RESULTS: Here, we present decompTumor2Sig, an easy to use R package that can decompose an individual tumor genome into a given set of Alexandrov-type or Shiraishi-type signatures, thus quantifying the contribution of the corresponding mutational processes to the somatic mutations identified in the tumor. Until now, such tools were available only for Alexandrov signatures. We demonstrate the correctness and usefulness of our approach with three test cases, using somatic mutations from 21 breast cancer genomes, from 435 tumor genomes of ten different tumor entities, and from simulated tumor genomes, respectively. CONCLUSIONS: The decompTumor2Sig package is freely available and has been accepted for inclusion in Bioconductor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2688-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6472187
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64721872019-04-24 decompTumor2Sig: identification of mutational signatures active in individual tumors Krüger, Sandra Piro, Rosario M. BMC Bioinformatics Research BACKGROUND: The somatic mutations found in a tumor have in most cases been caused by multiple mutational processes such as those related to extrinsic carcinogens like cigarette smoke, and those related to intrinsic processes like age-related spontaneous deamination of 5-methylcytosine. The effect of such mutational processes can be modeled by mutational signatures, of which two different conceptualizations exist: the model introduced by Alexandrov et al., Nature 500:415–421, 2013, and the model introduced by Shiraishi et al., PLoS Genetics 11(12):e1005657, 2015. The initial identification and definition of mutational signatures requires large sets of tumor samples. RESULTS: Here, we present decompTumor2Sig, an easy to use R package that can decompose an individual tumor genome into a given set of Alexandrov-type or Shiraishi-type signatures, thus quantifying the contribution of the corresponding mutational processes to the somatic mutations identified in the tumor. Until now, such tools were available only for Alexandrov signatures. We demonstrate the correctness and usefulness of our approach with three test cases, using somatic mutations from 21 breast cancer genomes, from 435 tumor genomes of ten different tumor entities, and from simulated tumor genomes, respectively. CONCLUSIONS: The decompTumor2Sig package is freely available and has been accepted for inclusion in Bioconductor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12859-019-2688-6) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-18 /pmc/articles/PMC6472187/ /pubmed/30999866 http://dx.doi.org/10.1186/s12859-019-2688-6 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Krüger, Sandra
Piro, Rosario M.
decompTumor2Sig: identification of mutational signatures active in individual tumors
title decompTumor2Sig: identification of mutational signatures active in individual tumors
title_full decompTumor2Sig: identification of mutational signatures active in individual tumors
title_fullStr decompTumor2Sig: identification of mutational signatures active in individual tumors
title_full_unstemmed decompTumor2Sig: identification of mutational signatures active in individual tumors
title_short decompTumor2Sig: identification of mutational signatures active in individual tumors
title_sort decomptumor2sig: identification of mutational signatures active in individual tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472187/
https://www.ncbi.nlm.nih.gov/pubmed/30999866
http://dx.doi.org/10.1186/s12859-019-2688-6
work_keys_str_mv AT krugersandra decomptumor2sigidentificationofmutationalsignaturesactiveinindividualtumors
AT pirorosariom decomptumor2sigidentificationofmutationalsignaturesactiveinindividualtumors